Lymph Node Evolution in Eyelid and Orbit Squamous Cell Carcinomas
The Laryngoscope · 2024
DOI: 10.1002/lary.31584 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Emilien Chebib und 12 weiteren Autor:innen. Beteiligte Einrichtung: Head & Neck Oncologic and Reconstructive Surgery Department, Institut Curie, Ear, Nose & Throat, Paris, France. Hauptthemen laut MEDLINE: Eyelid Neoplasms, Orbital Neoplasms, Lymphatic Metastasis, Lymph Nodes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
To describe a large cohort of eyelid and periorbital SCCs, to compare the location of the tumor and of the pathological lymph nodes, and to analyze the risk factors for lymph node involvement among tumor characteristics.
Methods
All patients managed inside our institution for an eyelid and periorbital SCCs were included. Tumor characteristics, imaging setup, excision margins, lymph node evolution features, local, regional, and distant recurrences rates, and global survival were reported. The risk for lymph node involvement and location of pathological lymph nodes were analyzed through univariate and multivariate analyses.
Results
Between January 2012 and August 2022, 115 patients were included, and 18 presented a lymph node evolution (15.7%), involving the parotid gland in 16 cases (88.9%), the submental and submandibular areas in seven cases (38%), and the jugular and carotid areas in four cases (22%). Tumor size above 20 mm, infiltration of the external canthus and periorbital structures, the presence of perineural invasion or vascular embolism, the depth of infiltration, and the presence of a local recurrence were significantly associated with the risk of lymph node evolution.
Conclusion
Periorbital and eyelid SCCs present a true potential for lymph node evolution especially through the parotid gland. Extension setup including the parotid gland and neck should be mandatory, and lymph node dissection should be associated in case of parotidectomy for lymph node involvement. Level of Evidence 4 Laryngoscope , 134:4956–4963, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Head & Neck Oncologic and Reconstructive Surgery Department, Institut Curie, Ear, Nose & Throat, Paris, France.
- Ophthalmology and Ocular Oncology Department, Institut Curie, Paris, France.
- Université Paris Cité, Paris, France.
- Radiation Oncology Department, Institut Curie, Paris, France.
ORCID-Profile: Emilien Chebib, Guillaume Rougier, Joey Martin, Olivier Choussy
Zitieren
APA
Chebib, E., Rougier, G., Dubray-Vautrin, A., Martin, J., Ghanem, W., Lesnik, M., Sabran, B., Matet, A., Malaise, D., Cassoux, N., Dendale, R., Choussy, O., & Badois, N. (2024). Lymph Node Evolution in Eyelid and Orbit Squamous Cell Carcinomas. The Laryngoscope. https://doi.org/10.1002/lary.31584
Vancouver
Chebib E, Rougier G, Dubray-Vautrin A, Martin J, Ghanem W, Lesnik M, et al. Lymph Node Evolution in Eyelid and Orbit Squamous Cell Carcinomas. The Laryngoscope. 2024. doi:10.1002/lary.31584
BibTeX
@article{Chebib2024,
author = {Chebib, Emilien and Rougier, Guillaume and Dubray-Vautrin, Antoine and Martin, Joey and Ghanem, Wahib and Lesnik, Maria and Sabran, Baptiste and Matet, Alexandre and Malaise, Denis and Cassoux, Nathalie and Dendale, Rémi and Choussy, Olivier and Badois, Nathalie},
title = {Lymph Node Evolution in Eyelid and Orbit Squamous Cell Carcinomas},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31584}
}
EUVIMED